Latest news with #DepartmentofDiseaseControl

Straits Times
4 days ago
- General
- Straits Times
Covid-19 cases surge in Thailand, over 28,000 new cases in two days
Covid-19 cases surge in Thailand, over 28,000 new cases in two days BANGKOK - Thailand's Department of Disease Control (DDC) on June 3 reported the Covid-19 situation for week 23 of 2025 via the digital disease surveillance (DDS) system. The latest data, as at June 2, showed 10,192 new cases. Previously, on June 1, there were 18,102 new cases, bringing the total new cases in the past two days to 28,294. Of the new cases, 9,304 were outpatients, and 888 were severe cases requiring hospitalisation. Additionally, one death was reported. As at May 27, the cumulative total of Covid-19 cases for 2025 stands at 323,301, with 69 deaths in total this year. Dr Taweesin Visanuyothin, director-general of the department of medical services, stated that the increasing number of cases is likely due to the early arrival of the rainy season and the opening of schools. He noted that this period also coincides with a rise in influenza cases, which have similar symptoms to Covid-19. In 2025, the reported 69 deaths were primarily among the '608 group', which includes elderly individuals and those with underlying conditions, particularly in large cities and tourist destinations like Bangkok (22 deaths), Chonburi (8 deaths), Chanthaburi (7 deaths), and Chiang Mai (3 deaths). The mortality rate remains low, at 0.106 per 100,000 people, suggesting that the disease is not becoming more severe. 'Non-high-risk individuals who get infected usually experience mild symptoms and can recover on their own or with over-the-counter treatments such as fever reducers, cough medicine, and decongestants. However, for high-risk groups such as the elderly or children under one year old, we urge immediate hospital visits,' said Dr Taweesin. Dr Suthat Chottanapund, deputy director-general of the DDC, explained that the increase in cases aligns with seasonal patterns. As schools reopen and the rainy season sets in, cases of upper respiratory infections tend to rise, particularly among students, where close contact can easily spread the virus. The DDC continues to emphasise personal preventive measures, such as social distancing, hand washing, and avoiding crowded places. While the mortality rate remains low, elderly groups are still a primary concern. An additional recommendation is to get the seasonal flu vaccine to prevent co-infection. 'Currently, the Covid-19 variant circulating in Thailand is XEC, which is more contagious but causes mild symptoms, similar to the flu. This is reflected in the low hospitalization rate, with many patients recovering on their own without medication. There is no need to suspend classes or work due to infection,' said Dr Suthat. Dr Sakan Bunnag, deputy director-general of the department of medical services, stated that distinguishing between mild symptoms of flu, common colds, and Covid-19 can be difficult. However, the initial care approach for all three is similar. For cases with mild symptoms and non-high-risk individuals, treatment is the same as for a regular cold, using symptomatic medications without the need for antiviral drugs. Those who should seek medical attention include patients whose symptoms worsen, such as those with a fever over 38.5 deg C, shortness of breath, fatigue, or blood oxygen levels below 95 per cent, he said. High-risk groups include elderly individuals, people with chronic illnesses, children under a year old, and pregnant women. Since Covid-19 is no longer considered a severe communicable disease, doctors will assess whether hospitalisation is necessary or whether medication should be prescribed. For patients with severe symptoms or those in high-risk groups, the main treatments are Remdesivir and Paxlovid. According to inquiries from various hospitals, these medications are still available directly from pharmaceutical companies and are not in short supply. Additionally, the Government Pharmaceutical Organisation is producing Molnupiravir for use in patients with moderate symptoms and no lung involvement, ensuring there will be no shortage of medications. 'There is no recommendation to stop working or self-quarantine when you are sick. Sick leave should be determined at the doctor's discretion, as with any other contagious disease. 'However, it is essential to wear a mask at all times, especially during the first five days of illness. Frequent hand washing and avoiding large group gatherings, such as meetings or shared meals, is important. If possible, continue wearing a mask for an additional three to five days. 'For schools, if multiple students are sick, those students should stay home, but there is no need to close classrooms or schools, as school-age children are generally not in the high-risk category for severe symptoms,' said Dr Sakan. THE NATION THAILAND/ASIA NEWS NETWORK Join ST's Telegram channel and get the latest breaking news delivered to you.


The Star
4 days ago
- General
- The Star
Covid-19 cases surge in Thailand, over 28,000 new cases in two days
BANGKOK: As of May 27, 2025, the cumulative total of Covid-19 cases in Thailand for 2025 stands at 323,301, with 69 deaths in total this year. The Department of Disease Control (DDC) on Tuesday (June 3) reported the Covid-19 situation for week 23 of 2025 via the Digital Disease Surveillance (DDS) system. The latest data, as of June 2, 2025, showed 10,192 new cases. Previously, on June 1, 2025, there were 18,102 new cases, bringing the total new cases in the past two days (June 1-2) to 28,294. Of the new cases, 9,304 were outpatients, and 888 were severe cases requiring hospitalization. Additionally, one death was reported. As of May 27, 2025, the cumulative total of Covid-19 cases for 2025 stands at 323,301, with 69 deaths in total this year. Dr Taweesin Visanuyothin, Director-General of the Department of Medical Services, stated that the increasing number of cases is likely due to the early arrival of the rainy season and the opening of schools. He noted that this period also coincides with a rise in influenza cases, which have similar symptoms to Covid-19. In 2025, the reported 69 deaths were primarily among the '608 group', which includes elderly individuals and those with underlying conditions, particularly in large cities and tourist destinations like Bangkok (22 deaths), Chonburi (eight deaths), Chanthaburi (seven deaths), and Chiang Mai (three deaths). The mortality rate remains low, at 0.106 per 100,000 people, suggesting that the disease is not becoming more severe. 'Non-high-risk individuals who get infected usually experience mild symptoms and can recover on their own or with over-the-counter treatments such as fever reducers, cough medicine, and decongestants. However, for high-risk groups such as the elderly or children under one year old, we urge immediate hospital visits,' said Taweesin. Dr Suthat Chottanapund, Deputy Director-General of the DDC, explained that the increase in cases aligns with seasonal patterns. As schools reopen and the rainy season sets in, cases of upper respiratory infections tend to rise, particularly among students, where close contact can easily spread the virus. The DDC continues to emphasise personal preventive measures, such as social distancing, hand washing, and avoiding crowded places. While the mortality rate remains low, elderly groups are still a primary concern. An additional recommendation is to get the seasonal flu vaccine to prevent co-infection. 'Currently, the Covid-19 variant circulating in Thailand is XEC, which is more contagious but causes mild symptoms, similar to the flu. This is reflected in the low hospitalisation rate, with many patients recovering on their own without medication. There is no need to suspend classes or work due to infection,' said Suthat. Dr Sakan Bunnag, Deputy Director-General of the Department of Medical Services, stated that distinguishing between mild symptoms of flu, common colds, and Covid-19 can be difficult. However, the initial care approach for all three is similar. For cases with mild symptoms and non-high-risk individuals, treatment is the same as for a regular cold, using symptomatic medications without the need for antiviral drugs. Those who should seek medical attention include patients whose symptoms worsen, such as those with a fever over 38.5°C, shortness of breath, fatigue, or blood oxygen levels below 95%, he said. High-risk groups include elderly individuals, people with chronic illnesses, children under one year old, and pregnant women. Since Covid-19 is no longer considered a severe communicable disease, doctors will assess whether hospitalisation is necessary or whether medication should be prescribed. For patients with severe symptoms or those in high-risk groups, the main treatments are Remdesivir and Paxlovid. According to inquiries from various hospitals, these medications are still available directly from pharmaceutical companies and are not in short supply. Additionally, the Government Pharmaceutical Organization is producing Molnupiravir for use in patients with moderate symptoms and no lung involvement, ensuring there will be no shortage of medications. "There is no recommendation to stop working or self-quarantine when you are sick. Sick leave should be determined at the doctor's discretion, as with any other contagious disease. "However, it is essential to wear a mask at all times, especially during the first five days of illness. Frequent hand washing and avoiding large group gatherings, such as meetings or shared meals, is important. If possible, continue wearing a mask for an additional three to five days. "For schools, if multiple students are sick, those students should stay home, but there is no need to close classrooms or schools, as school-age children are generally not in the high-risk category for severe symptoms," said Sakan. - The Nation/ANN


Time of India
20-05-2025
- Health
- Time of India
Covid-19 resurgence: JN.1 variant drives surge in new cases in Southeast Asia—what's causing the sudden spike?
Is COVID-19 back in India? After almost five years, the virus is here again to haunt us. Currently, Southeast Asia, including Hong Kong, Singapore, and Thailand, is witnessing a surge in COVID-19 cases. However, India is no exception; the country has reported 257 mild cases so far, as of May 20, 2025. According to PTI, India reported 257 fresh COVID-19 cases and is currently monitoring the situation minutely. However, most of the cases are mild in nature with no unusual severity. On the other hand, Hong Kong, Singapore, Thailand, and even China have reported a spike in a fresh wave of COVID-19 cases over the past few weeks. But what led to the sudden spike in cases in Asia? Reasons behind the sudden spike in COVID-19 cases in Asia According to Singapore's health ministry, from April 27 to May 3, 2025, the estimated number of COVID-19 cases suddenly jumped to 14,200 cases from 11,100 reported last week. Over the same time, the average daily count of COVID-19 hospitalisations rose from 102 to 133; however, the average daily Intensive Care Unit (ICU) cases reduced from three to two cases. A similar incident was noted in Thailand, where the cases spiked from 6,000 on May 17 to 33,030 on May 11, as per the Department of Disease Control. While something similar was noted in Hong Kong as well. Attributing what are the reasons that led to the sudden spike in cases in these countries, the Singapore health authorities mentioned linking it to the waning immunity among the population and the spread of new variants, such as LF.7 and NB.1.8, which are descendants of the JN.1 variant that emerged in 2024. Who is at risk of the JN.1 variant? The report went on to mention that as the new cases are being reported, it is an indication that protection from previous infections or vaccinations is gradually decreasing over time. 'Since the COVID-19 cases are rapidly rising in the country because of the JN.1 variant, it's crucial to adopt preventive measures to prevent the infection,' says Dr. Harish Chafle, Senior Consultant Intensivist, Chest Physician, Bronchoscopist, and Sleep Disorders Specialist at Gleneagles Hospital Parel, Mumbai. 'Even though the infection is mild, follow these precautionary measures,' he adds. ⚠️ BREAKING: China 🇨🇳 Hit by New COVID Surge Driven by Omicron XDV and NB.1.8.1 Variants Hospitals Overwhelmed, Beijing Warns of Delayed Response Importance of masks and handwashing It is necessary to wear a mask when in crowded or poorly ventilated areas. 'Wash your hands with soap and water, and also sanitise them after touching any surface or object. Don't come in contact with individuals who are sick. Take the COVID-19 vaccination and booster shot without any further delay. Seek timely attention if you notice symptoms such as fever, cough, headaches, and sore throat,' advises Dr. Chafle. 'Masks should be made compulsory at heavily crowded public places,' he adds. However, according to Dr. Divya Joshi, consultant in infectious diseases at Fortis Hospital, Bannerghatta Road, there is no need to hurry to buy any masks just yet. Indian health authorities say there is no cause for alarm as the COVID-19 situation seems to be well under control, and the circulating viral strains do not appear to be more virulent than before. You could still go wrong preparing yourself, especially if you have compromised immunity or pre-existing conditions. 'If you are in a higher risk category or are in a crowded venue or exhibit symptoms, wear a mask. Check with the doctor if you have a viral respiratory infection and take precautions appropriately if you are in a high-risk group or see a spike in cases,' she adds. To stay updated on the stories that are going viral follow Indiatimes Trending.


NDTV
20-05-2025
- Health
- NDTV
Covid-19 Cases Spike In Asia: About JN.1 Variant And Affected Countries
In Thailand, most of the infections were in those aged between 30 and 39. New Delhi: A resurgent wave of Covid-19 is spreading through Southeast Asia, with densely populated regions in Hong Kong, Singapore, China and Thailand witnessing a spike in cases. Health authorities are on alert in major cities like Hong Kong and Singapore, China and Thailand have asked people to take new booster vaccinations. Most Affected Countries According to the Hong Kong's Center for Health Protection, the virus' activity in the city is now "quite high." The percentage of respiratory samples testing Covid-positive in Hong Kong recently reached its highest in a year. In the week ending May 3, Hong Kong reported 31 severe cases, which is a 12-month peak, according to a report by Bloomberg. While the resurgence is yet to match the infection peaks seen in the past two years, the rise of viral load in sewage water and Covid-related medical consultations and hospitalisations suggests the infection is spreading actively in the city of over 7 million people. In Singapore, the health ministry said the number of Covid--19 cases has jumped 28 per cent to 14,200 in the week ending May 3, with daily hospitalisations rising around 30 per cent. Notably, this is the first time in nearly a year that the Singaporean government has released official figures in this manner, as the country now only provides case updates when there is a noticeable spike. "While the increase in cases could be due to factors including waning population immunity, there is no indication that the circulating variants are more transmissible - or cause more severe cases - than during the pandemic," Singapore's health ministry said. A similar trend was reported in Thailand, where Covid-19 cases spiked to 33,030 in the week ending May 17, doubling from 16,000 cases reported in the previous week, according to the Department of Disease Control. Authorities said most cases were reported in Bangkok (6,290), followed by Chon Buri (2,573), Rayong (1,680), and Nonthaburi (1,482). Most of the infections were in those aged between 30 and 39, with Thai public health authorities urging people, especially those in high-risk groups, to get booster vaccinations without delay. The resurgence of infection in the cases followed the Songkran festival in April, which involved widespread gatherings and is believed to have accelerated transmission. Covid-19 cases are also rising in China, where the Center for Disease Control and Prevention said that from March 31 to May 4, the COVID-19 positivity rate among outpatient and emergency influenza-like cases nationwide increased from 7.5 per cent to 16.2 per cent. The positivity rate of hospitalised cases also increased from 3.3 per cent to 6.3 per cent, according to The sudden rise in cases is considered a warning sign that China may be entering a wave similar to that experienced during the previous summer. Meanwhile, India also witnessed a rise in Covid-19 cases in the past week, with the Ministry of Health and Family Welfare reporting 257 active cases nationwide. However, there has been no sign of an outbreak so far, with authorities closely monitoring the situation. New Variant The driver behind the surge of Covid-19 cases in Asia is reportedly the JN.1 variant and its related descendants, which are a subvariant of the Omicron lineage. The World Health Organisation (WHO) has designated JN.1 as "variant of interest", though not yet a "variant of concern." That suggests that authorities are closely monitoring the situation, but there's no conclusive evidence so far that it causes more severe illness like the other Omicron subvariants.
&w=3840&q=100)

First Post
20-05-2025
- Health
- First Post
Covid surge in Asia: Cases double in Thailand in a week, most infections among 30-39 age-group
The new wave of COVID-19 infections is affecting people aged between 30 to 39 in Thailand, as authorities advise citizens to wear face masks and use an antigen test kit (ATK) if they develop symptoms of fever, cough or fatigue read more A medical worker in a protective suit registers information for a patient at the entrance to the fever clinic of the Central Hospital of Wuhan in Hubei province, China on December 31, 2022. (Representative Photo, Credit: Reuters) Thailand reported 33,030 COVID-19 cases last week, with at least 6,000 infections reported in Bangkok, the country's Department of Disease Control has said. It said that coronavirus cases recorded between May 11 and 17 doubled from the 16,000 cases reported the previous week. Local media reports indicate that out of the total number of infections, 1,918 individuals have been hospitalised, while two deaths have been reported from Sukhothai and Kanchanaburi provinces. The new wave of COVID-19 infections is affecting people aged between 30 to 39 in Thailand, as authorities advise citizens to wear face masks and use an antigen test kit (ATK) if they develop symptoms of fever, cough or fatigue. STORY CONTINUES BELOW THIS AD New COVID variant on the loose? Meanwhile, the virus has also been spreading in Singapore , with cases rising from 14,200 cases in the first week of May, as compared to 11,100 cases in the week before that. 'At present, LF.7 and NB.1.8 (both descendants of the JN.1 variant) are the main COVID-19 variants circulating in Singapore, together accounting for more than two-thirds of locally sequenced cases. JN.1 is also the variant used in the formulation of the current COVID-19 vaccine,' Singapore's Ministry of Health said. The authorities said that the increase in COVID-19 infections could be due to several factors, including waning population immunity, and expect periodic waves of the viral infection throughout the year, similar to other endemic respiratory diseases. Should you be worried? Health authorities in India are keeping an eye on reports of a rise in COVID cases in Singapore and Hong Kong, even as official sources, earlier this week, asserted the current coronavirus situation in the country was under control. A review meeting of experts from the National Centre for Disease Control, Emergency Medical Relief division, Disaster Management Cell, Indian Council of Medical Research and Central government hospitals was held on Monday under the chairpersonship of the director general of health services. 'The meeting concluded that the current COVID-19 situation in India remains under control. As of May 19, 2025, the number of active COVID-19 cases in India stands at 257, a very low figure considering the country's large population. With inputs from agencies